Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor Cells

SIMPLE SUMMARY: The clinical implementation of novel precision medicine strategies in high-grade serous ovarian cancer (HGSOC), the most common and aggressive ovarian cancer subtype, are urgently needed. Targeted immunotherapeutic combinations that maximize drug benefits are of particular interest....

Descripción completa

Detalles Bibliográficos
Autores principales: Gerton, Thomas J., Green, Allen, Campisi, Marco, Chen, Minyue, Gjeci, Iliana, Mahadevan, Navin, Lee, Catherine A. A., Mishra, Ranjan, Vo, Ha V., Haratani, Koji, Li, Ze-Hua, Hasselblatt, Kathleen T., Testino, Bryanna, Connor, Trevor, Lian, Christine G., Elias, Kevin M., Lizotte, Patrick, Ivanova, Elena V., Barbie, David A., Dinulescu, Daniela M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452550/
https://www.ncbi.nlm.nih.gov/pubmed/37627156
http://dx.doi.org/10.3390/cancers15164128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452550/
https://www.ncbi.nlm.nih.gov/pubmed/37627156
http://dx.doi.org/10.3390/cancers15164128

Ejemplares similares